Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab (COMPASS)

NCT01402544 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT01402544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01402544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab (COMPASS)
Lead sponsor
University of California, San Diego
Phase
Phase 2/3
Overall status
Terminated
Start date
July 31, 2011
Completion date
March 31, 2015
Enrollment
20 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration